USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Solta Medical Ireland Limited

USPTO PatentsView assignee record - 12 granted patents across 6 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

The verdict

According to USPTO PatentsView, Solta ranks #23,428 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 6 technology areas.

#23,428
of 50,000 US assignees by volume
Top 29%
by Innovation Score (42.9/100)
9.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R23428 · Foreign Corporation #23,428 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 12 grants
  • MID-PACK #23,428/50,000
  • PHOTO-FINISH Smiths Heimann SAS
  • CPC-NARROW A61B · 6 areas
  • INNOV-PAR 42.9/100
  • CLAIMS-PAR 9.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2022–2025 · 4y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Smiths Heimann SAS (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Solta

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Solta's Innovation Score is 42.9/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Solta's grants concentrate

Solta Medical Ireland Limited is a focused PatentsView assignee: 6 CPC subclasses with 41.7% of grants classified under A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2023. By volume, Solta sits between Smiths Heimann SAS and Spartan Motors, Inc..

Who files at Solta's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Solta holds 12 patents at rank #23,454, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Solta

By rank, the assignees closest to #23,454 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Solta's primary technology class.

Solta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2022202320242025 4
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Solta Medical Ireland Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 3 25.0%
2023 1 8.3%
2024 4 33.3%
2025partial year 4 33.3%

Where it ranks

Overall rank by patents

#23,428

of 50,000 tracked assignees

Innovation Score

42.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.